Frankfurt - Delayed Quote EUR
Viking Therapeutics, Inc. (1VT.F)
22.01
+0.18
+(0.85%)
As of 8:06:17 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-87,790
-87,790
-73,376
-48,397
-47,586
Investing Cash Flow
-553,366
-553,366
-179,086
54,753
37,960
Financing Cash Flow
612,464
612,464
271,376
4,163
6,880
End Cash Position
26,676
26,676
55,516
36,632
26,371
Issuance of Capital Stock
597,094
597,094
269,760
--
--
Repurchase of Capital Stock
--
--
--
-6,817
--
Free Cash Flow
-87,790
-87,790
-73,376
-48,397
-47,586
12/31/2021 - 5/11/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PI3.DU Gubra AS
46.80
-2.94%
LYTIX.OL Lytix Biopharma AS
5.18
-3.72%
ASMB Assembly Biosciences, Inc.
10.52
+1.05%
SPRB Spruce Biosciences, Inc.
0.1339
+0.75%
PTCT PTC Therapeutics, Inc.
49.31
-1.29%
LCTX Lineage Cell Therapeutics, Inc.
0.4743
+0.49%
VNDA Vanda Pharmaceuticals Inc.
4.3350
+0.12%
GRCE Grace Therapeutics, Inc.
2.3500
+2.62%
CANF Can-Fite BioPharma Ltd.
1.1900
+0.85%
TSHA Taysha Gene Therapies, Inc.
1.8150
-0.27%